- Canada
- /
- Healthtech
- /
- TSX:VHI
Exploring High Growth Tech Stocks This May 2026
As global markets experience a rally fueled by strong corporate earnings and robust U.S. labor data, technology stocks have emerged as key drivers of growth, particularly those involved in artificial intelligence infrastructure. In this environment, identifying high-growth tech stocks involves looking for companies that are well-positioned to capitalize on technological advancements and demonstrate resilience amid evolving market dynamics.
Top 10 High Growth Tech Companies Globally
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Hacksaw | 25.39% | 24.80% | ★★★★★★ |
| Shengyi Electronics | 26.78% | 32.30% | ★★★★★★ |
| Zhongji Innolight | 41.90% | 44.62% | ★★★★★★ |
| Fositek | 28.54% | 37.56% | ★★★★★★ |
| ISU Petasys | 27.23% | 34.54% | ★★★★★★ |
| Suzhou TFC Optical Communication | 42.81% | 41.23% | ★★★★★★ |
| Unimicron Technology | 29.87% | 54.56% | ★★★★★★ |
| Bonesupport Holding | 23.74% | 34.48% | ★★★★★★ |
| KebNi | 26.87% | 82.69% | ★★★★★★ |
| CARsgen Therapeutics Holdings | 64.21% | 83.56% | ★★★★★★ |
Let's review some notable picks from our screened stocks.
Seco (BIT:IOT)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Seco S.p.A. is a technology company specializing in innovative solutions for the digitization of industrial products and processes across various global markets, with a market cap of approximately €349.13 million.
Operations: Seco S.p.A. generates revenue primarily through its core segments, Seco (€147.50 million) and Seco NE (€60.98 million).
Seco's recent performance and strategic presentations underscore its resilience and potential in a challenging tech landscape. In 2025, the company increased its sales to €197.58 million from €183.51 million the previous year, reflecting a growth of 7.67%, while significantly reducing its net loss to €2.69 million from €21.03 million, indicating robust operational improvements and cost management strategies. These financial advancements are complemented by Seco’s commitment to innovation as evidenced at the Euronext Milan STAR Conference, highlighting their forward-looking approach in a rapidly evolving sector. Despite current unprofitability, Seco is expected to pivot into profitability within three years with an anticipated earnings growth of 58.23% per annum, outpacing many peers in the IoT domain where average growth lags behind this figure. Moreover, Seco’s R&D dedication is pivotal for maintaining competitive advantage; however specific figures on R&D spending were not disclosed which could be crucial for investors assessing long-term value creation through innovation pipelines in high-tech industries like IoT where technological leadership is key to sustainability and market share gains.
- Click here to discover the nuances of Seco with our detailed analytical health report.
Gain insights into Seco's past trends and performance with our Past report.
2CRSI (ENXTPA:AL2SI)
Simply Wall St Growth Rating: ★★★★★★
Overview: 2CRSI S.A. and its subsidiaries focus on developing, manufacturing, and distributing comprehensive computing solutions both in France and globally, with a market capitalization of €794.27 million.
Operations: The company generates revenue primarily through the sales of components and finished products, amounting to €405.21 million.
2CRSI's recent strategic moves and financial performance underscore its robust positioning in the high-growth tech sector. With a significant revenue increase to €207.05 million from €21.76 million, the company has demonstrated an impressive annualized revenue growth of 25.8%. This surge is supported by a strong earnings uptick, with net income rising to €8.57 million from €2.55 million year-over-year, marking a substantial growth rate of 65.4%. The firm's commitment to research and development is evident from its latest collaboration with Chemours on advanced cooling technologies for AI servers, ensuring it stays at the forefront of innovation in high-density IT infrastructure solutions. This focus on cutting-edge technology development is critical as 2CRSI navigates through supply chain challenges while maintaining a dynamic order backlog and targeting an EBITDA above €36 million for the fiscal year.
- Navigate through the intricacies of 2CRSI with our comprehensive health report here.
Review our historical performance report to gain insights into 2CRSI's's past performance.
Vitalhub (TSX:VHI)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Vitalhub Corp. offers technology and software solutions for health and human service providers across Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally with a market cap of CA$504.18 million.
Operations: Vitalhub Corp. generates revenue by providing technology and software solutions tailored for health and human service sectors across multiple regions, including Canada, the U.S., the U.K., Australia, and Western Asia. The company has a market capitalization of CA$504.18 million.
Vitalhub's recent financial performance showcases robust growth, with a 58% increase in annual revenue to CAD 108.97 million and a doubling of net income to CAD 6.11 million for the full year ended December 31, 2025. The company's commitment to innovation is further evidenced by its significant R&D investments, aligning with industry trends towards enhanced healthcare technology solutions. With earnings expected to grow by an impressive 39.5% annually over the next three years and a recent quarterly report showing continued positive momentum—revenue up to CAD 31.91 million from CAD 21.67 million—Vitalhub is strategically positioned within the high-growth tech landscape, particularly in healthcare services where it outpaces industry growth rates significantly.
Next Steps
- Get an in-depth perspective on all 193 Global High Growth Tech and AI Stocks by using our screener here.
- Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
- Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSX:VHI
Vitalhub
Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.
Flawless balance sheet with reasonable growth potential.
Similar Companies
Market Insights
Weekly Picks

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

Mastercard: The Best Dividend Stock You're Ignoring

A Wonderful Business at a Not-So-Wonderful Price

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect
Recently Updated Narratives

CAR Group. A wonderful compounding franchise at a fair-not-cheap price.
Palantir hits 52 week low.
EWY:US NYSE Arca iShares Msci South Korea ETF, an opportunity to diversify your tech investments.
Popular Narratives

Adobe: A Probabilistic Case for Undervaluation

Investment Analysis (May 2026)
